The irrational use of antimicrobials has led to the emergence of resistance, impacting not only pathogenic bacteria but also commensal bacteria. Resistance against colistin, a last-resort antibiotic, mediated by globally disseminated plasmid-borne mobile colistin resistance (mcr) genes, has raised significant global concerns. This cross-sectional study aimed to investigate the antimicrobial resistance patterns of colistin-resistant Escherichia coli (E. coli) and mobilised colistin resistance (mcr 1–5) genes from broiler meat. A total of 570 broiler samples (285 liver and 285 muscle) were collected from 7 supermarkets and 11 live bird markets (LBMs) in Chattogram metropolitan areas of Bangladesh. The isolation and identification of E. coli were carried out using standard bacteriological and molecular techniques. Antimicrobial susceptibility testing (AST) was performed using the Kirby–Bauer disc diffusion method, and colistin’s minimum inhibitory concentration (MIC) was determined by the broth microdilution (BMD) method. Colistin-resistant isolates were further tested for the presence of mcr (1–5) genes using polymerase chain reaction (PCR). Out of the 570 samples, 311 (54.56%; 95% confidence interval: 50.46–58.60) were positive for E. coli. AST results showed the highest resistance to sulphamethoxazole–trimethoprim (89.39%), while the highest susceptibility was observed for cefalexin (62.70%). A total of 296 isolates (95.18%) were found to be multidrug-resistant (MDR), with the multiple antibiotic resistance (MAR) index ranging from 0.38 to 1. Additionally, 41 isolates (13.18%) exhibited resistance to five antimicrobial classes, with resistance patterns of CIP + SXT + AMP + DO + TE + CT. A total of 233 isolates (74.92%) were resistant to colistin (MIC > 2 mg/L). A strong correlation between colistin resistance and the presence of the mcr-1 gene was observed (r = 1). All phenotypic colistin-resistant E. coli isolates carried the mcr-1 gene, while no isolates were positive for mcr (2–5). The detection of mcr genes in E. coli strains from poultry sources poses a significant risk, as these resistance genes can be transferred to humans through the food chain. The prevalence of multidrug-resistant Escherichia coli and the mcr-1 gene in poultry products in Bangladesh presents a significant public health and food safety concern.

Introduction: This study aimed to evaluate the impact of lactobacilli-based direct-fed microbial (DFM) supplementation on the composition and diversity of the ruminal microbiota in dairy cows. Understanding how DFM influences microbial populations can inform strategies to enhance animal health and productivity.Methods: Over a 16-month period (September 2021 to January 2023), ruminal fluid samples were collected from fifty dairy cows assigned to either a DFM-supplemented group (DFM; n = 25) or an unsupplemented control group (CON; n = 25). Microbial DNA was extracted and subjected to 16S rRNA gene amplification and sequencing. Microbial diversity was assessed using alpha- and beta-diversity metrics (p < 0.05), and linear discriminant analysis effect size (LEfSe) was employed to identify differentially abundant taxa. Multivariable analyses were used to explore associations with age, average milk production, days in milk (DIM), time, and supplementation.Results: The dominant bacterial phyla identified were Bacillota and Bacteroidota, while Methanobacteriaceae was the predominant archaeal family. The DFM group showed significantly higher abundance of genera such as Eubacterium_Q, Atopobium sp. UBA7741, and Sharpea (p < 0.05). Conversely, Bacillus_P_294101 and SFMI01 were more abundant in the CON group. Temporal changes in microbial composition were observed, with significant differences in community diversity and structure between groups over time.Discussion: These findings demonstrate that lactobacilli-based DFM supplementation can significantly alter the ruminal microbial ecosystem in dairy cows. The observed microbial shifts, including increases in beneficial bacterial taxa, highlight the potential of DFM as a nutritional strategy to modulate rumen function and improve dairy cow performance.

The One Health concept highlights the interconnectedness of human, animal, and environmental health and places significant importance on plant biosecurity. This is due to the profound impact of plant biosecurity on food safety and security for animals and people, biodiversity, and the economy. This narrative review examines the roles of government and industry as risk creators and mitigators in plant biosecurity within a One Health framework, focusing on how their collaboration can strengthen surveillance, enhance regulatory policies, and mitigate the spread of plant pests and diseases. Plant biosecurity, which encompasses the measures to safeguard plant biosecurity and life in the same way that animal biosecurity safeguards animal and human health and life, is a critical component of One Health. Measures include a range of policies, regulations, strategies and activities to protect plants from exotic and established pests and diseases. Government, industry, and community actions are critical elements of plant biosecurity. These include pest surveillance and the establishment and maintenance of pest-free areas. Government agencies and industry professionals play a central and pivotal role in shaping plant biosecurity by implementing policies and regulations and developing innovative strategies. These actions can have a dual effect on plant biosecurity: they can either mitigate risks by preventing the introduction and spread of pests or create risks if regulations are inadequate or poorly enforced. The success of plant biosecurity efforts depends on how well government policies align with One Health principles, which require a careful balance between economic, environmental, social and health-related technical/scientific considerations. Pest surveillance, a foundational element of plant biosecurity, provides the tools for early detection and rapid response to pest outbreaks, essential for protecting plant biosecurity. Surveillance programs enable continuous monitoring of pest populations and the detection of emerging threats, which is critical for maintaining pest-free areas. The benefits of pest surveillance are numerous and extend beyond plant biosecurity, contributing to broader One Health objectives by reducing the risk of zoonotic diseases and preserving the ecological integrity of ecosystems. It underpins important economic and trade objectives by projecting confidence in the safety and health of Australia’s agricultural products to international trading partners. Strategies to achieve and maintain pest-free areas include stringent quarantine measures, continuous surveillance, and effective rapid response protocols. The interconnectedness of plant biosecurity with One Health is evident in these efforts, as maintaining pest-free areas supports ecosystem health, minimises the need for chemical interventions and consequent pressure on antimicrobial resistance, and promotes sustainable agricultural practices. Government actions, pest surveillance, and the maintenance of pest-free regions are essential components of a robust plant biosecurity strategy. By aligning these measures with One Health principles, it is possible to protect plant biosecurity, enhance environmental sustainability, and contribute to global health outcomes. This holistic approach highlights the importance of cross-sector collaboration and the need for solid biosecurity frameworks to safeguard plant biosecurity in an increasingly interconnected world.

Antimicrobial resistance (AMR) is a growing global concern and poses a significant threat to public health. The emergence of multidrug-resistant organisms, including Escherichia coli, also presents a risk of transmission to humans through the food chain, including milk. This study aimed to investigate the prevalence of E. coli in raw milk in the Chattogram metropolitan area (CMA) of Bangladesh and their phenotypic and genotypic antimicrobial resistance patterns. A total of 450 raw cow milk samples were collected from 18 farms within the CMA. The isolation and identification of E. coli were performed following standard bacteriological methods. Antimicrobial susceptibility testing (AST) was conducted using the Kirby–Bauer disc diffusion method. Molecular detection of E. coli and antimicrobial resistance genes was performed using the Polymerase Chain Reaction (PCR). This study found 134 (29.77%) milk samples that tested positive for E. coli. Antimicrobial susceptibility testing (AST) revealed the highest resistance rates (69.40%) to be for ampicillin, amoxicillin–clavulanic acid, cephalothin, and cephalexin, with the lowest resistance (21.64%) being for norfloxacin. A significant correlation (r = 1) was observed between ciprofloxacin and ceftazidime resistance among the antimicrobials tested. All E. coli isolates were classified as multidrug-resistant (MDR), being resistant to three or more antimicrobial classes, with a multiple resistance index >0.2. PCR amplification showed that the bla_TEM gene had the highest prevalence (74.19%) among the ESBL and antimicrobial resistance genes tested. In contrast, the bla_CMY-1 gene had a lower prevalence (6.45%) among the ESBL genes, while the tetD gene had the lowest prevalence (2.9%) among the resistance genes tested. Positive correlations were observed between antimicrobial resistance and the presence of these resistance genes. This study emphasises the high prevalence of MDR E. coli in raw cow milk and its significant potential impact on public health. It underscores the urgent need for strategic interventions to effectively manage and mitigate AMR in the Bangladeshi dairy sector, focusing on the prudent use of antimicrobials and implementing enhanced AMR surveillance.

Paratuberculosis is a chronic zoonotic bacterial infection, primarily affecting ruminants. This review examines the disease in the Arabian Peninsula, focusing on distribution, molecular diversity, prevalence, and associated risk factors. Following PRISMA guidelines, a systematic search was conducted in PubMed, Scopus, and Web of Science. After duplicate removal and eligibility screening, data extraction, analysis, and quality assessment were performed. Pathogen sequences were retrieved from NCBI GenBank for phylogenetic analysis. The review included a total of 31 published articles from 1997 to 2025, of which 26 were used in the meta-analysis. Most studies (n = 12) were published between 2011 and 2015, predominantly from Saudi Arabia (n = 22), with no reports from Qatar, Bahrain, or Yemen. The majority of the studies involved camels and sheep (n = 16 on each species), followed by cattle (n = 9), goats (n = 7), humans (n = 2), and buffalo (n = 1). Phylogenetic analysis delineates two major clades—Type S and Type C—suggesting greater genetic diversity in Type S. The estimated pooled seroprevalence and pathogen prevalence in livestock ruminants were 8.1% and 22.4%, respectively. Herd-level estimated pooled seroprevalence was 26.9%. Small ruminants (19.3%) were more sero-prevalent than large ruminants (7.4%), with goats (28.7%) significantly (p < 0.01) more affected than sheep (21.5%), camel (9.8%), and cattle (6.6%). Clinical signs in ruminants included chronic diarrhea, emaciation, anorexia, alopecia, wry neck, and dehydration. The reviewed study patterns and findings suggest high pathogen diversity and a significant risk of transboundary transmission at the human–animal interface in this region. A One Health surveillance approach is crucial, particularly on farms with diarrheic and emaciated animals. Establishing a national surveillance plan and phased (short-, intermediate-, and long-term) control programs is essential to mitigate economic losses, limit transmission, overcome the cultural barrier, and protect public health.

Epstein–Barr virus (EBV), also known as human herpesvirus 4, is a member of the herpes virus family. EBV is a widespread virus and causes infectious mononucleosis, which manifests with symptoms such as fever, fatigue, lymphadenopathy, splenomegaly, and hepatomegaly. Additionally, EBV is associated with different lymphocyte-associated non-malignant, premalignant, and malignant diseases. So far, no effective treatment or therapeutic drug is known for EBV-induced infections and diseases. This study investigated natural compounds that inhibit EBV glycoprotein L (gL) and block EBV fusion in host cells. We utilised computational approaches, including molecular docking, in silico ADMET analysis, and molecular dynamics simulation. We docked 628 natural compounds against gL and identified the four best compounds based on binding scores and pharmacokinetic properties. These four compounds, with PubChem CIDs 4835509 (CHx-HHPD-Ac), 2870247 (Cyh-GlcNAc), 21206004 (Hep-HHPD-Ac), and 51066638 (Und-GlcNAc), showed several interactions with EBV gL. However, molecular dynamics simulations indicated that the protein–ligand complexes of CID: 4835509 (CHx-HHPD-Ac) and CID: 2870247 (Cyh-GlcNAc) are more stable than those of the other two compounds. Therefore, CIDs 4835509 and 2870247 (Cyh-GlcNAc) may be potent natural inhibitors of EBV infection. These findings can open a new way for effective drug design against EBV and its associated infections and diseases.